Elevated levels of the acute‐phase serum amyloid are associated with heightened lung cancer risk

The authors investigated whether early stage lung cancer could be identified by proteomic analyses of plasma.

[1]  D. Chan,et al.  Identification of Biomarkers for Breast Cancer in Nipple Aspiration and Ductal Lavage Fluid , 2005, Clinical Cancer Research.

[2]  William L. Bigbee,et al.  Diagnostic Accuracy of MALDI Mass Spectrometric Analysis of Unfractionated Serum in Lung Cancer , 2007, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[3]  B. Adam,et al.  Serum protein profile analysis in patients with head and neck squamous cell carcinoma. , 2006, Archives of otolaryngology--head & neck surgery.

[4]  Ugo Pastorino,et al.  Computed tomography screening and lung cancer outcomes. , 2007, JAMA.

[5]  T. Yip,et al.  Identification of Serum Amyloid A Protein As a Potentially Useful Biomarker to Monitor Relapse of Nasopharyngeal Cancer by Serum Proteomic Profiling , 2004, Clinical Cancer Research.

[6]  Weijian Guo,et al.  Prediction of Pancreatic Cancer by Serum Biomarkers Using Surface-Enhanced Laser Desorption/Ionization-Based Decision Tree Classification , 2005, Oncology.

[7]  R. Badolato,et al.  Serum amyloid A is a chemoattractant: induction of migration, adhesion, and tissue infiltration of monocytes and polymorphonuclear leukocytes , 1994, The Journal of experimental medicine.

[8]  F. D. de Beer,et al.  Human serum amyloid A (SAA) protein: a prominent acute‐phase reactant for clinical practice , 1996, European journal of clinical investigation.

[9]  Victor G Zgoda,et al.  Ovarian cancer marker of 11.7 kDa detected by proteomics is a serum amyloid A1 , 2005, Proteomics.

[10]  Wei Zhang,et al.  Application of serum SELDI proteomic patterns in diagnosis of lung cancer , 2005, BMC Cancer.

[11]  Carole Mathelin,et al.  Serum biomarkers for detection of breast cancers: a prospective study , 2006, Breast Cancer Research and Treatment.

[12]  D. Smallwood,et al.  Serum amyloid a is a biomarker of acute exacerbations of chronic obstructive pulmonary disease. , 2008, American journal of respiratory and critical care medicine.

[13]  M. Pierotti,et al.  RET oncoproteins induce tyrosine phosphorylation changes of proteins involved in RNA metabolism. , 2006, Cellular signalling.

[14]  T. Yip,et al.  New desorption strategies for the mass spectrometric analysis of macromolecules , 1993 .

[15]  D. Metcalfe,et al.  Extracellular matrix-anchored serum amyloid A preferentially induces mast cell adhesion. , 1997, The American journal of physiology.

[16]  P. Simpson,et al.  Statistical methods in cancer research , 2001, Journal of surgical oncology.

[17]  S. Flibotte,et al.  Identification of serum amyloid A as a biomarker to distinguish prostate cancer patients with bone lesions. , 2005, Clinical chemistry.

[18]  E. Malle,et al.  Serum amyloid A: An acute-phase protein involved in tumour pathogenesis , 2008, Cellular and Molecular Life Sciences.

[19]  Jiekai Yu,et al.  SELDI-TOF-MS: the proteomics and bioinformatics approaches in the diagnosis of breast cancer. , 2005, Breast.

[20]  Ron Kohavi,et al.  A Study of Cross-Validation and Bootstrap for Accuracy Estimation and Model Selection , 1995, IJCAI.

[21]  C. Maury,et al.  Comparative study of serum amyloid A protein and C-reactive protein in disease. , 1985, Clinical science.

[22]  W. Y. Zhang,et al.  Serum proteomic features for detection of endometrial cancer , 2005, International Journal of Gynecologic Cancer.

[23]  M. Campa,et al.  Clinical utility of serum amyloid A and macrophage migration inhibitory factor as serum biomarkers for the detection of nonsmall cell lung carcinoma , 2004, Cancer.

[24]  P. Sharp,et al.  Evolution of the serum amyloid A (SAA) protein superfamily. , 1994, Genomics.

[25]  N. Breslow,et al.  Statistical methods in cancer research: volume 1- The analysis of case-control studies , 1980 .

[26]  T. Yamada,et al.  Serum Amyloid A (SAA): a Concise Review of Biology, Assay Methods and Clinical Usefulness , 1999, Clinical chemistry and laboratory medicine.

[27]  D. Hayes,et al.  Uses and abuses of tumor markers in the diagnosis, monitoring, and treatment of primary and metastatic breast cancer. , 2006, The oncologist.

[28]  Shu Zheng,et al.  Application of serum protein fingerprint in diagnosis of papillary thyroid carcinoma , 2006, Proteomics.

[29]  Susan R. Wilson,et al.  Proteomic classification of pancreatic adenocarcinoma tissue using protein chip technology. , 2006, Gastroenterology.

[30]  Robert Tibshirani,et al.  The Use of Plasma Surface-Enhanced Laser Desorption/Ionization Time-of-Flight Mass Spectrometry Proteomic Patterns for Detection of Head and Neck Squamous Cell Cancers , 2004, Clinical Cancer Research.